J. Whitaker
Chief Tech/Sci/R&D Officer presso OMEROS CORPORATION
Profilo
J.
Steven Whitaker is currently the Vice President-Clinical Development at Omeros Corp.
He previously worked as the Divisional Vice President at ICOS Corp from 1994 to 2007 and as the Chief Medical Officer & VP-Clinical Development at Allon Therapeutics, Inc. from 2008 to 2010.
Whitaker holds a graduate degree from the University of Washington, an undergraduate degree from Butler University, and a doctorate degree from The Indiana University School of Medicine.
Posizioni attive di J. Whitaker
| Società | Posizione | Inizio |
|---|---|---|
| OMEROS CORPORATION | Chief Tech/Sci/R&D Officer | 01/11/2019 |
Precedenti posizioni note di J. Whitaker
| Società | Posizione | Fine |
|---|---|---|
| ALLON THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/03/2010 |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Corporate Officer/Principal | 01/05/2007 |
Formazione di J. Whitaker
| University of Washington | Graduate Degree |
| Butler University | Undergraduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| OMEROS CORPORATION | Health Technology |
| ALLON THERAPEUTICS INC. | Health Technology |
| Aziende private | 1 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
- Borsa valori
- Insiders
- J. Whitaker
